Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Ischemic Heart Disease

  Free Subscription


08.03.2021

1 Am Heart J
11 Am J Cardiol
1 Am J Emerg Med
5 Angiology
1 Ann Intern Med
2 Ann Thorac Surg
1 Arterioscler Thromb Vasc Biol
1 BMJ
2 Br J Haematol
4 Catheter Cardiovasc Interv
1 Circ Cardiovasc Imaging
4 Circ Cardiovasc Interv
5 Circ Cardiovasc Qual Outcomes
1 Circ Genom Precis Med
3 Circ J
1 Circ Res
2 Circulation
1 Clin Cardiol
2 Dtsch Med Wochenschr
14 Eur Heart J
3 Hypertension
3 Int J Cardiol
5 J Am Coll Cardiol
1 J Cardiovasc Pharmacol
3 J Clin Epidemiol
2 J Mol Cell Cardiol
3 J Thorac Cardiovasc Surg
2 JAMA
3 Lancet
4 Mayo Clin Proc
1 N Engl J Med
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am Heart J

  1. AKAO M, Yasuda S, Kaikita K, Ako J, et al
    Rivaroxaban Monotherapy versus Combination Therapy According to Patient Risk of Stroke and Bleeding in Atrial Fibrillation and Stable Coronary Disease: AFIRE trial sub-analysis.
    Am Heart J. 2021 Feb 28. pii: S0002-8703(21)00063.
    PubMed         Abstract available


    Am J Cardiol

  2. SHAH T, Haimi I, Yang Y, Gaston S, et al
    Meta-Analysis of Sex Disparities in In-hospital Care and Outcomes in Patients with ST-Segment Elevation Myocardial Infarction.
    Am J Cardiol. 2021 Feb 25. pii: S0002-9149(21)00164.
    PubMed         Abstract available

  3. WEALE ME, Riveros-Mckay F, Selzam S, Seth P, et al
    Validation of an Integrated Risk Tool, Including Polygenic Risk Score, for Atherosclerotic Cardiovascular Disease in Multiple Ethnicities and Ancestries.
    Am J Cardiol. 2021 Mar 3. pii: S0002-9149(21)00207.
    PubMed         Abstract available

  4. KAMRAN H, Malhotra R, Farhan S, Masoomi R, et al
    Meta-Analysis of Anticoagulation Therapy for the Prevention of Cardiovascular Events in Patients with Peripheral Arterial Disease.
    Am J Cardiol. 2021 Mar 2. pii: S0002-9149(21)00208.
    PubMed         Abstract available

  5. HESS NR, Sultan I, Wang Y, Thoma F, et al
    Comparison of Aspirin Monotherapy versus Dual Antiplatelet Therapy Following Coronary Artery Bypass Grafting.
    Am J Cardiol. 2021 Mar 2. pii: S0002-9149(21)00201.
    PubMed         Abstract available

  6. OBISESAN OH, Osei AD, Berman D, Dardari ZA, et al
    Thoracic Aortic Calcium For The Prediction Of Stroke Mortality (From The Coronary Artery Calcium Consortium).
    Am J Cardiol. 2021 Mar 2. pii: S0002-9149(21)00213.
    PubMed         Abstract available

  7. KANENAWA K, Yamaji K, Tashiro H, Morimoto T, et al
    Frailty and Bleeding after Percutaneous Coronary Intervention.
    Am J Cardiol. 2021 Mar 2. pii: S0002-9149(21)00216.
    PubMed         Abstract available

  8. MILLER AB, Januzzi JL, O'Neill BJ, Gundapaneni B, et al
    Causes of Cardiovascular Hospitalization and Death in Patients with Transthyretin Amyloid Cardiomyopathy (From the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial [ATTR-ACT]).
    Am J Cardiol. 2021 Mar 2. pii: S0002-9149(21)00210.
    PubMed         Abstract available

  9. CLARKSON S, Heindl B, Cai A, Beasley M, et al
    Outcomes of Individuals With and Without Heart Failure Presenting With Acute Coronary Syndrome.
    Am J Cardiol. 2021 Mar 2. pii: S0002-9149(21)00202.
    PubMed         Abstract available

  10. ARNETT EN, Roberts WC
    Degrees of Cross-Sectional-Area Luminal Narrowing of the Four Major Epicardial Coronary Arteries in Patients with Otherwise Functionally and Anatomically Normal Hearts.
    Am J Cardiol. 2021 Feb 26. pii: S0002-9149(21)00154.
    PubMed         Abstract available

  11. LOPES RD, Thomas L, Di Fusco M, Keshishian A, et al
    Clinical and Economic Outcomes Among Non-Valvular Atrial Fibrillation Patients with Coronary Artery Disease and/or Peripheral Artery Disease.
    Am J Cardiol. 2021 Mar 2. pii: S0002-9149(21)00196.
    PubMed         Abstract available

  12. BISWAS S, Dinh D, Andrianopoulos N, Lefkovits J, et al
    Comparison of Long-Term Outcomes After Percutaneous Coronary Intervention in Patients With Insulin-Treated vs. Non-Insulin Treated Diabetes Mellitus.
    Am J Cardiol. 2021 Mar 2. pii: S0002-9149(21)00200.
    PubMed         Abstract available


    Am J Emerg Med

  13. BRUOHA S, Yosefy C, Gallego-Colon E, Rieck J, et al
    Impact in total ischemic time and ST-segment elevation myocardial infarction admissions during COVID-19.
    Am J Emerg Med. 2021;45:7-10.
    PubMed         Abstract available


    Angiology

  14. GAO K, Li BL, Zhang M, Rong J, et al
    Long-Term Outcomes of Percutaneous Coronary Intervention for Patients With In-Stent Chronic Total Occlusion Versus De Novo Chronic Total Occlusion.
    Angiology. 2021 Mar 4:3319721998575. doi: 10.1177/0003319721998575.
    PubMed         Abstract available

  15. OFORI-ASENSO R, Mohsenpour MA, Nouri M, Faghih S, et al
    Association of Spicy Chilli Food Consumption With Cardiovascular and All-Cause Mortality: A Meta-Analysis of Prospective Cohort Studies.
    Angiology. 2021 Mar 4:3319721995666. doi: 10.1177/0003319721995666.
    PubMed         Abstract available

  16. CIRAKOGLU OF, Karadeniz AG, Akyuz AR, Aydin C, et al
    Abdominal Aortic Intima-Media Thickness Predicts Coronary Artery Disease Severity in Patients With Stable Angina Pectoris: A Prospective Study.
    Angiology. 2021 Mar 5:3319721998853. doi: 10.1177/0003319721998853.
    PubMed         Abstract available

  17. ATES AH, Yorgun H, Canpolat U, Kaya EB, et al
    Long-Term Prognostic Value of Coronary Atherosclerotic Plaque Characteristics Assessed by Computerized Tomographic Angiography.
    Angiology. 2020 Oct 29:3319720963677. doi: 10.1177/0003319720963677.
    PubMed         Abstract available

  18. NAFAKHI H, Al-Mosawi AA, Al-Buthabhak K
    Sex-Related Differences in the Association of BMI and Pericardial Fat Volume With Coronary Atherosclerotic Markers in Young.
    Angiology. 2021;72:285-289.
    PubMed         Abstract available


    Ann Intern Med

  19. NANNA MG, Newby LK
    In coronary artery disease, PCI increases all-cause and cause-specific mortality compared with CABG.
    Ann Intern Med. 2021 Mar 2. doi: 10.7326/ACPJ202103160.
    PubMed         Abstract available


    Ann Thorac Surg

  20. KACHROO P
    Gender based outcomes following surgical revascularization in stable coronary disease patients: Decades later and questions remain.
    Ann Thorac Surg. 2021 Mar 3. pii: S0003-4975(21)00419.
    PubMed        

  21. HU X, Jiang W, Li H, Zhou T, et al
    Prosthesis selection for aortic valve replacement with concomitant coronary artery bypass graft.
    Ann Thorac Surg. 2021 Mar 2. pii: S0003-4975(21)00363.
    PubMed         Abstract available


    Arterioscler Thromb Vasc Biol

  22. ZEGEYE MM, Andersson JSO, Wennberg P, Repsilber D, et al
    IL-6 as a Mediator of the Association Between Traditional Risk Factors and Future Myocardial Infarction: A Nested Case-Control Study.
    Arterioscler Thromb Vasc Biol. 2021 Mar 4:ATVBAHA120315793.
    PubMed         Abstract available


    BMJ

  23. STEWART RAH, Jones P, Dicker B, Jiang Y, et al
    High flow oxygen and risk of mortality in patients with a suspected acute coronary syndrome: pragmatic, cluster randomised, crossover trial.
    BMJ. 2021;372:n355.
    PubMed         Abstract available


    Br J Haematol

  24. CORNELL RF, Goldhaber SZ, Engelhardt BG, Moslehi J, et al
    Primary prevention of venous thromboembolism with apixaban for multiple myeloma patients receiving immunomodulatory agents.
    Br J Haematol. 2020;190:555-561.
    PubMed         Abstract available

  25. PASTORI D, Lip GYH, Poli D, Antonucci E, et al
    Determinants of low-quality warfarin anticoagulation in patients with mechanical prosthetic heart valves. The nationwide PLECTRUM study.
    Br J Haematol. 2020;190:588-593.
    PubMed         Abstract available


    Catheter Cardiovasc Interv

  26. TABAZA L, Virk HUH, Janzer S, George JC, et al
    Robotic-assisted percutaneous coronary intervention in a COVID-19 patient.
    Catheter Cardiovasc Interv. 2020 May 20. doi: 10.1002/ccd.28982.
    PubMed         Abstract available

  27. BORTNICK AE
    COVID-19: The personal and professional impact of one case.
    Catheter Cardiovasc Interv. 2021;97:E352-E353.
    PubMed        

  28. ROTHSTEIN ES, Welch TD, Andrus BW, Jayne JE, et al
    Management of a patient presenting with anterior STEMI with concomitant COVID-19 infection early in the course of the U.S. pandemic.
    Catheter Cardiovasc Interv. 2021;97:E333-E338.
    PubMed         Abstract available

  29. CASTAGNA F, Cerrud-Rodriguez R, Villela MA, Bortnick AE, et al
    SARS-COV-2 infection presenting as ST-elevationmyocardial infarction.
    Catheter Cardiovasc Interv. 2021;97:E339-E342.
    PubMed         Abstract available


    Circ Cardiovasc Imaging

  30. LUSTOSA RP, Butcher SC, van der Bijl P, El Mahdiui M, et al
    Global Left Ventricular Myocardial Work Efficiency and Long-Term Prognosis in Patients After ST-Segment-Elevation Myocardial Infarction.
    Circ Cardiovasc Imaging. 2021 Mar 2:CIRCIMAGING120012072.
    PubMed         Abstract available


    Circ Cardiovasc Interv

  31. CAPODANNO D
    Evolving Landscapes in Coronary Stents for Patients at High Bleeding Risk.
    Circ Cardiovasc Interv. 2021 Mar 1:CIRCINTERVENTIONS121010591.
    PubMed        

  32. HEIDENREICH PA
    Using Discontinuity to Cross the Quality Chasm.
    Circ Cardiovasc Interv. 2020;13:e009887.
    PubMed        

  33. KAUL P, Kandzari DE
    Chronic Total Occlusions: Practice Makes Perfect-Implications for Standardizing Performance and Training.
    Circ Cardiovasc Interv. 2020;13:e009724.
    PubMed        

  34. NANNA MG, Navar AM
    Teaching Old Treatments New Tricks.
    Circ Cardiovasc Interv. 2020;13:e009725.
    PubMed        


    Circ Cardiovasc Qual Outcomes

  35. LEVY AE, Hammes A, Anoff DL, Raines JD, et al
    Acute Myocardial Infarction Cohorts Defined by International Classification of Diseases, Tenth Revision Versus Diagnosis-Related Groups: Analysis of Diagnostic Agreement and Quality Measures in an Integrated Health System.
    Circ Cardiovasc Qual Outcomes. 2021 Mar 3:CIRCOUTCOMES120006570.
    PubMed         Abstract available

  36. SHEN YC, Krumholz H, Hsia RY
    Association of Cardiac Care Regionalization With Access, Treatment, and Mortality Among Patients With ST-Segment Elevation Myocardial Infarction.
    Circ Cardiovasc Qual Outcomes. 2021 Mar 1:CIRCOUTCOMES120007195.
    PubMed         Abstract available

  37. SANDHU AT, Do R, Lam J, Blankenship J, et al
    Development of the Elective Outpatient Percutaneous Coronary Intervention Episode-Based Cost Measure.
    Circ Cardiovasc Qual Outcomes. 2021 Mar 3:CIRCOUTCOMES119006461.
    PubMed         Abstract available

  38. JOYNT MADDOX KE, Johnston KJ
    Value-Based Cardiovascular Care: Developing Cost Measures for Percutaneous Coronary Intervention.
    Circ Cardiovasc Qual Outcomes. 2021 Mar 3:CIRCOUTCOMES121007753.
    PubMed        

  39. HARRINGTON JL, Granger CB
    Standardizing ST-Segment Elevation Myocardial Infarction Care: Customizing Regionalization to Improve Outcomes.
    Circ Cardiovasc Qual Outcomes. 2021 Mar 1:CIRCOUTCOMES120007701.
    PubMed        


    Circ Genom Precis Med

  40. RIVEROS-MCKAY F, Weale ME, Moore R, Selzam S, et al
    An Integrated Polygenic Tool Substantially Enhances Coronary Artery Disease Prediction.
    Circ Genom Precis Med. 2021 Mar 2. doi: 10.1161/CIRCGEN.120.003304.
    PubMed         Abstract available


    Circ J

  41. PELLEGRINI D, Fiocca L, Pescetelli I, Canova P, et al
    Effect of Respiratory Impairment on the Outcomes of Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction and Coronavirus Disease-2019 (COVID-19).
    Circ J. 2021 Mar 2. doi: 10.1253/circj.CJ-20-1166.
    PubMed         Abstract available

  42. MATOBA T, Sakamoto K, Nakai M, Ichimura K, et al
    Institutional Characteristics and Prognosis of Acute Myocardial Infarction With Cardiogenic Shock in Japan- Analysis From the JROAD/JROAD-DPC Database.
    Circ J. 2021 Mar 4. doi: 10.1253/circj.CJ-20-0655.
    PubMed         Abstract available

  43. GOTO S, Ichihara G, Katsumata Y, Ko S, et al
    Time-Series Transcriptome Analysis Reveals the miR-27a-5p-Ppm1l Axis as a New Pathway Regulating Macrophage Alternative Polarization After Myocardial Infarction.
    Circ J. 2021 Mar 3. doi: 10.1253/circj.CJ-20-0783.
    PubMed         Abstract available


    Circ Res

  44. GOOD ME, Young A, Wolpe AG, Ma M, et al
    Endothelial Pannexin 1 Regulates Cardiac Response to Myocardial Infarction.
    Circ Res. 2021 Mar 1. doi: 10.1161/CIRCRESAHA.120.317272.
    PubMed        


    Circulation

  45. HENRY TD, Tomey MI, Tamis-Holland JE, Thiele H, et al
    Invasive Management of Acute Myocardial Infarction Complicated by Cardiogenic Shock: A Scientific Statement From the American Heart Association.
    Circulation. 2021 Mar 4:CIR0000000000000959. doi: 10.1161/CIR.0000000000000959.
    PubMed         Abstract available

  46. PENG AW, Dardari ZA, Blumenthal RS, Dzaye O, et al
    Very High Coronary Artery Calcium (CAC >/= 1000) and Association with CVD Events, Non-CVD Outcomes, and Mortality: Results from The Multi-Ethnic Study of Atherosclerosis (MESA).
    Circulation. 2021 Mar 2. doi: 10.1161/CIRCULATIONAHA.120.050545.
    PubMed         Abstract available


    Clin Cardiol

  47. NAGUMO S, Collet C, Norgaard BL, Otake H, et al
    Rationale and design of the precise percutaneous coronary intervention plan (P3) study: Prospective evaluation of a virtual computed tomography-based percutaneous intervention planner.
    Clin Cardiol. 2021 Mar 3. doi: 10.1002/clc.23551.
    PubMed         Abstract available


    Dtsch Med Wochenschr

  48. KLOTH C, Kirsten J, Liu Y, Steinacker JM, et al
    [56-year-old patient with bagging of the left ventricle after a heart attack].
    Dtsch Med Wochenschr. 2020;145:1297-1298.
    PubMed        

  49. WANNER C, Galle J, Lopau K
    [Kidney as pacemaker for cardiovascular aging].
    Dtsch Med Wochenschr. 2021;146:317-322.
    PubMed         Abstract available


    Eur Heart J

  50. KNUUTI J, Wijns W, Saraste A, Capodanno D, et al
    2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes.
    Eur Heart J. 2020;41:407-477.
    PubMed        

  51. ALI ZA, McEntegart M, Hill JM, Spratt JC, et al
    Intravascular lithotripsy for treatment of stent underexpansion secondary to severe coronary calcification.
    Eur Heart J. 2020;41:485-486.
    PubMed        

  52. HILVO M, Meikle PJ, Pedersen ER, Tell GS, et al
    Development and validation of a ceramide- and phospholipid-based cardiovascular risk estimation score for coronary artery disease patients.
    Eur Heart J. 2020;41:371-380.
    PubMed         Abstract available

  53. HESS CN, Hiatt WR
    Progress in the prevention and treatment of atherosclerotic cardiovascular disease: two steps forward, one step back.
    Eur Heart J. 2020;41:1650-1652.
    PubMed        

  54. PRATI F, Romagnoli E, Gatto L, La Manna A, et al
    Relationship between coronary plaque morphology of the left anterior descending artery and 12 months clinical outcome: the CLIMA study.
    Eur Heart J. 2020;41:383-391.
    PubMed         Abstract available

  55. CEGLAREK U, Schellong P, Rosolowski M, Scholz M, et al
    The novel cystatin C, lactate, interleukin-6, and N-terminal pro-B-type natriuretic peptide (CLIP)-based mortality risk score in cardiogenic shock after acute myocardial infarction.
    Eur Heart J. 2021 Feb 27. pii: 6153946. doi: 10.1093.
    PubMed         Abstract available

  56. BJORNSTAD JL, Bendz B
    Periprocedural myocardial injury in the EXCEL trial.
    Eur Heart J. 2020;41:1703.
    PubMed        

  57. MESSERLI FH, Bangalore S, Messerli AW, Raber L, et al
    The muddy waters of the J-curve and coronary revascularization.
    Eur Heart J. 2020 Mar 2. pii: 5771269. doi: 10.1093.
    PubMed        

  58. SORBETS E, Fox KM, Elbez Y, Danchin N, et al
    Long-term outcomes of chronic coronary syndrome worldwide: insights from the international CLARIFY registry.
    Eur Heart J. 2020;41:347-356.
    PubMed         Abstract available

  59. LUSCHER TF
    Chronic coronary syndromes: expanding the spectrum and natural history of ischaemic heart disease.
    Eur Heart J. 2020;41:333-336.
    PubMed        

  60. IANNACCONE M, Brilakis ES, Boccuzzi GG
    An App for complex PCI solutions.
    Eur Heart J. 2020;41:342-344.
    PubMed        

  61. LOPEZ-JIMENEZ F, Gersh BJ
    Secondary prevention after coronary artery bypass grafting saves lives: a golden opportunity often wasted.
    Eur Heart J. 2019 Dec 4. pii: 5651910. doi: 10.1093.
    PubMed        

  62. AL'AREF SJ, Maliakal G, Singh G, van Rosendael AR, et al
    Machine learning of clinical variables and coronary artery calcium scoring for the prediction of obstructive coronary artery disease on coronary computed tomography angiography: analysis from the CONFIRM registry.
    Eur Heart J. 2020;41:359-367.
    PubMed         Abstract available

  63. BAUMBACH A, Bourantas CV, Serruys PW, Wijns W, et al
    The year in cardiology: coronary interventions.
    Eur Heart J. 2020 Jan 6. pii: 5694318. doi: 10.1093.
    PubMed        


    Hypertension

  64. ARGUNHAN F, Thapa D, Aubdool AA, Carlini E, et al
    Calcitonin Gene-Related Peptide Protects Against Cardiovascular Dysfunction Independently of Nitric Oxide In Vivo.
    Hypertension. 2021 Mar 1:HYPERTENSIONAHA12014851.
    PubMed         Abstract available

  65. LEE H, Yano Y, Cho SMJ, Heo JE, et al
    Adherence to Antihypertensive Medication and Incident Cardiovascular Events in Young Adults With Hypertension.
    Hypertension. 2021 Mar 1:HYPERTENSIONAHA12016784.
    PubMed         Abstract available

  66. PARCHA V, Malla G, Kalra R, Li P, et al
    Coronary Artery Calcium Score for Personalization of Antihypertensive Therapy: A Pooled Cohort Analysis.
    Hypertension. 2021 Mar 1:HYPERTENSIONAHA12016689.
    PubMed         Abstract available


    Int J Cardiol

  67. KISHI T
    Clinical implication of left ventricular preload and afterload reduction during venoarterial extracorporeal membrane oxygenation.
    Int J Cardiol. 2020;320:124-125.
    PubMed        

  68. TZIAKAS D, Chalikias G, Al-Lamee R, Kaski JC, et al
    Non ST-elevation myocardial infarction (NSTEMI) patients with total coronary artery occlusion: More than meets the eye.
    Int J Cardiol. 2021 Feb 26. pii: S0167-5273(21)00367.
    PubMed        

  69. WANG JD, Qiu F, Li W
    miRNA-1: A novel, potential therapeutic target in the treatment of acute myocardial infarction?
    Int J Cardiol. 2021 Feb 28. pii: S0167-5273(21)00374.
    PubMed        


    J Am Coll Cardiol

  70. WILBER DJ
    Early Post-Infarction Survival in the Modern Era: Reinforcing Old Lessons.
    J Am Coll Cardiol. 2020;76:2937-2939.
    PubMed        

  71. WILLIAMS N, Sulistio MS, Winchester DE, Chen C, et al
    How to Build an Antiracist Cardiovascular Culture, Community, and Profession.
    J Am Coll Cardiol. 2021;77:1257-1261.
    PubMed        

  72. VILLINES TC, Rodriguez Lozano P
    Transitioning From Stenosis to Plaque Burden in the Cardiac CT Era: The Changing Risk Paradigm.
    J Am Coll Cardiol. 2020;76:2814-2816.
    PubMed        

  73. GIGER RD, du Fay de Lavallaz J, Prepoudis A, Stoll T, et al
    Rhabdomyolysis: A Noncardiac Source of Increased Circulating Concentrations of Cardiac Troponin T?
    J Am Coll Cardiol. 2020;76:2685-2687.
    PubMed        

  74. BRUGALETTA S, Gomez-Lara J, Ortega-Paz L, Jimenez-Diaz V, et al
    10-Year Follow-Up of Patients With Everolimus-Eluting Versus Bare-Metal Stents After ST-Segment Elevation Myocardial Infarction.
    J Am Coll Cardiol. 2021;77:1165-1178.
    PubMed         Abstract available


    J Cardiovasc Pharmacol

  75. VILHENA JC, Lopes de Melo Cunha L, Jorge TM, de Lucena Machado M, et al
    Acai reverses adverse cardiovascular remodeling in renovascular hypertension: a comparative effect with Enalapril.
    J Cardiovasc Pharmacol. 2021 Feb 19. pii: 00005344-900000000-98275.
    PubMed         Abstract available


    J Clin Epidemiol

  76. PEDERSEN E, Truong KNL, Garcia BH, Halvorsen KH, et al
    Self-reported medication use among coronary heart disease patients showed high validity compared with dispensing data.
    J Clin Epidemiol. 2021 Feb 25. pii: S0895-4356(21)00052.
    PubMed         Abstract available

  77. WEBSTER-CLARK M, Baron JA, Jonsson Funk M, Westreich D, et al
    How subgroup analyses can miss the trees for the forest plots: A simulation study.
    J Clin Epidemiol. 2020;126:65-70.
    PubMed         Abstract available

  78. ERKELENS DC, Rutten FH, Wouters LT, de Groot E, et al
    Limited reliability of experts' assessment of telephone triage in primary care patients with chest discomfort.
    J Clin Epidemiol. 2020;127:117-124.
    PubMed         Abstract available


    J Mol Cell Cardiol

  79. NAKAYAMA Y, Mukai N, Wang BF, Yang K, et al
    Txnip C247S mutation protects the heart against acute myocardial infarction.
    J Mol Cell Cardiol. 2021 Feb 27. pii: S0022-2828(21)00048.
    PubMed         Abstract available

  80. MCCULLOCH A, Grandi E, Saucerman J
    Computational models of cardiovascular regulatory mechanisms.
    J Mol Cell Cardiol. 2021 Feb 26. pii: S0022-2828(21)00027.
    PubMed        


    J Thorac Cardiovasc Surg

  81. DIMAGLI A, Benedetto U
    Commentary: "Do or do not. There is no try": Which role for minimally invasive direct coronary artery bypass?
    J Thorac Cardiovasc Surg. 2021 Feb 5. pii: S0022-5223(21)00232.
    PubMed        

  82. LOCKER C
    Reply: Skeletonized bilateral internal thoracic artery grafting is a quality metric in coronary artery bypass grafting.
    J Thorac Cardiovasc Surg. 2021 Feb 24. pii: S0022-5223(21)00110.
    PubMed        

  83. GAUDINO M, Brophy JM
    The controversy on the treatment of left main coronary artery disease.
    J Thorac Cardiovasc Surg. 2020 Nov 10. pii: S0022-5223(20)33039.
    PubMed        


    JAMA

  84. YOU SC, Gupta A, Krumholz HM
    Ticagrelor vs Clopidogrel for Patients With Acute Coronary Syndrome Undergoing Percutaneous Intervention-Reply.
    JAMA. 2021;325:890-891.
    PubMed        

  85. KIM HK, Kubica J, Jeong YH
    Ticagrelor vs Clopidogrel for Patients With Acute Coronary Syndrome Undergoing Percutaneous Intervention.
    JAMA. 2021;325:890.
    PubMed        


    Lancet

  86. CORDERO A, Rodriguez-Manero M, Bertomeu-Gonzalez V, Gonzalez-Juanatey JR, et al
    Managing NSTEMI in older patients.
    Lancet. 2021;397:370-371.
    PubMed        

  87. KAURA A, Sterne JAC, Trickey A, Mayet J, et al
    Managing NSTEMI in older patients - Authors' reply.
    Lancet. 2021;397:371-372.
    PubMed        

  88. VERSACI F, Frati G, Biondi-Zoccai G
    Managing NSTEMI in older patients.
    Lancet. 2021;397:370.
    PubMed        


    Mayo Clin Proc

  89. BARILLAS-LARA MI, Medina-Inojosa JR, Kolla BP, Smith JR, et al
    The Association of Sleep Apnea and Cardiorespiratory Fitness With Long-Term Major Cardiovascular Events.
    Mayo Clin Proc. 2021;96:636-647.
    PubMed         Abstract available

  90. NAARAAYAN A, Nimkar A, Jesmajian S, Gitler B, et al
    Atherosclerotic Cardiovascular Disease Prevalence Among Patients With Celiac Disease in the United States: An Observational Study.
    Mayo Clin Proc. 2021;96:666-676.
    PubMed         Abstract available

  91. GERSH FL, O'Keefe JH, Henry BM
    COVID-19, the Female Immune Advantage, and Cardiovascular Impact.
    Mayo Clin Proc. 2021;96:820-821.
    PubMed        

  92. RITTER O, Kararigas G
    In Reply - COVID-19, the Female Immune Advantage, and Cardiovascular Impact.
    Mayo Clin Proc. 2021;96:821-822.
    PubMed        


    N Engl J Med

  93. GIBBONS GH, Seidman CE, Topol EJ
    Conquering Atherosclerotic Cardiovascular Disease - 50 Years of Progress.
    N Engl J Med. 2021;384:785-788.
    PubMed        


    PLoS One

  94. HOFFMANN DB, Fraccarollo D, Galuppo P, Frantz S, et al
    Genetic ablation of fibroblast activation protein alpha attenuates left ventricular dilation after myocardial infarction.
    PLoS One. 2021;16:e0248196.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: